Publication not explained
This publication has not yet been explained in plain language by the author(s). However, you can still read the publication.
If you are one of the authors, claim this publication so you can create a plain language summary to help more people find, understand and use it.
Featured Image
Read the Original
This page is a summary of: Synthesis, docking study, and structure-activity relationship of novel niflumic acid derivatives acting as anticancer agents by inhibiting VEGFR or EGFR tyrosine kinase activities, Pharmacia, July 2022, Pensoft Publishers,
DOI: 10.3897/pharmacia.69.e86504.
You can read the full text:
Contributors
The following have contributed to this page
